Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J/DePuy Spine launches Healos Fx

This article was originally published in The Gray Sheet

Executive Summary

Injectable bone graft replacement designed specifically for minimally invasive spine surgery debuts April 27. The 510(k)-cleared Healos Fx is a ready-to-use fibrous material that can be molded for open applications or "injected via cannulas of differing lengths to reach difficult implantation sites in minimally invasive or small void surgical environments," the firm states. When saturated with a patient's bone marrow, Healos Fx serves as a continuous scaffold for bone formation and the osteoprogenitor cells needed to initiate new bone growth, according to the company. Healos in strip form has been available in the U.S. for over seven years, the firm notes
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT027395

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel